Trial intelligence / Profile preview

Remimazolam Sedation for Bronchoscopy: Single-Arm Prospective Pilot Study

jRCTs051250268Recruiting

Start
Apr 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of remimazolam in Conditions requiring diagnostic bronchoscopy with biopsy. Primary endpoint: Completion of the planned bronchoscopy examination. Started Apr 2026; status: recruiting.

02

Drugs

remimazolam
03

Conditions

Conditions requiring diagnostic bronchoscopy with biopsy

Beyond the preview

Go deeper on jRCTs051250268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051250268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call